L. Adamek

机构：AstraZeneca (United Kingdom), AstraZeneca (Singapore)

发表论文 48 篇 · 总被引 2397 次 · h-index 15

代表论文

• Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years (2012 · European Respiratory Review · 被引 251)
• Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification (2012 · European Respiratory Journal · 被引 214)
• Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations (2013 · Respiratory Medicine · 被引 59)
• Severe T2-high asthma in the biologics era: European experts' opinion (2019 · European Respiratory Review · 被引 43)
• Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe (2012 · Primary Care Respiratory Journal · 被引 43)
• Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study (2019 · Respiratory Research · 被引 33)